Pricing Log in Create free account

Gelteq Limited (GELS) vs InMed Pharmaceuticals Inc. (INM)

Gelteq Limited and InMed Pharmaceuticals Inc. are both Drug Manufacturers Specialty & Generic companies. InMed Pharmaceuticals Inc. is the larger, with a market value of $7.3M against $4.9M — 1.5× the size. Across the 7 metrics below, Gelteq Limited leads on 4 and InMed Pharmaceuticals Inc. on 3.

Valuation

Metric GELS INM Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S — 15.78 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 15.54 2.87
Earnings yield — (23.08%) (15.94%)
Free cash flow yield 0.00% (11.11%) 0.00%

Profitability

Metric GELS INM Drug Manufacturers Specialty & Generic median
Gross margin — 33.62% 53.51%
Operating margin — 0.00% 0.00%
Net margin — 0.00% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (261.69%) (0.80%)
Return on assets 0.00% (185.40%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GELS INM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (6.73%) 5.22%
EPS growth (last fiscal year) (62.07%) 62.68% 42.91%
Revenue growth, 5-year CAGR — — 7.24%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GELS INM Drug Manufacturers Specialty & Generic median
Debt to equity 0.36 0.00 0.04
Current ratio 0.09 0.50 2.41
Net debt to EBITDA (0.91) 0.20 1.01

Dividend

Metric GELS INM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric GELS INM Drug Manufacturers Specialty & Generic median
Market cap 4.88m 7.26m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack